In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Viroptic, Trifluorothymidine, Trifluridine Drug Master File in Korea (Viroptic, Trifluorothymidine, Trifluridine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Viroptic, Trifluorothymidine, Trifluridine. The MFDS reviews the Viroptic, Trifluorothymidine, Trifluridine KDMF as part of the drug registration process and uses the information provided in the Viroptic, Trifluorothymidine, Trifluridine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Viroptic, Trifluorothymidine, Trifluridine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Viroptic, Trifluorothymidine, Trifluridine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Viroptic, Trifluorothymidine, Trifluridine suppliers with KDMF on PharmaCompass.